Fierce Pharma

APRIL 11, 2024

The American Society of Health-System Pharmacists has released new data showing there were 323 drugs in shortage in the U.S. As lawmakers, biopharma companies and others try to stabilize vulnerable pharma supply chains, drug shortages have become about as bad as they’ve ever been in the U.S. |

Biopharma 327

Biopharma Pharma 327

Copyright Clearance Center

FEBRUARY 14, 2023

The post The American Society for Microbiology Adopts CCC RightsLink for Scientific Communications to Manage its Growing Open Access Program appeared first on Copyright Clearance Center.

Management 96

Management 96

pharmaphorum

MARCH 18, 2024

The PM Society’s 38th annual awards were held last week, on Friday 15th March, at the JW Marriott Grosvenor House London, at which over 900 industry professionals came together to celebrate the best in creative, impactful, and innovative communications in pharma and healthcare.

Pharma 88

Pharma Healthcare Healthcare 88

pharmaphorum

SEPTEMBER 21, 2022

As a spokesperson for the PM Society commented, “We were very cognisant and respectful of events unfolding beyond the awards, but after much consideration and speaking with attendees, we decided to go ahead and we’re so glad that we did. The post 13th PM Society Digital Awards – celebrating creative innovation appeared first on.

Education 56

Education Healthcare Healthcare Recruitment 56

Fierce Pharma

FEBRUARY 9, 2024

the American Society of Clinical Oncologists (ASCO) is again pushing Congress to act to end the crisis. | A year into a dire shortage of essential cancer medicines in the U.S.,

Doctors 312

Doctors Medicine Medical 312

Contrarian Sales Techniques

FEBRUARY 21, 2023

How A Pharma Sales Rep Can Contribute to Society One way that pharma sales reps can contribute to society is by ensuring that healthcare providers are informed about the latest advances in treatments and therapies. This can have a significant impact on patient outcomes and overall public health.

Pharma sales reps 40

Pharma sales reps Sales Pharma Healthcare Provider 40

Copyright Clearance Center

JANUARY 17, 2023

. – CCC , a leading provider of Open Access (OA) workflow solutions, announces the American Society for Microbiology (ASM), has adopted RightsLink for Scientific Communications (RLSC) to manage its growing OA program. ASM is one of the largest life science societies, composed of more than 30,000 scientists and health professionals.

Management 52

Management Government Education Training 52

Fierce Pharma

OCTOBER 24, 2023

At this year’s congress of the European Society for Medical Oncology (ESMO), Merck & Co. unleashed a flurry of studies showing Keytruda’s power across multiple tumor types.

Medical 296

Medical 296

Fierce Pharma

DECEMBER 5, 2023

In its letter to congressional leaders, the American Cancer Society Cancer Action Network (ACS CAN) outlined the root causes of drug shortages and offered potential solutions. As the year comes to a close, shortages of key cancer drugs have no end in sight. |

Patients 246

Patients Networking 246

PharmExec

MARCH 15, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

MedCity News

DECEMBER 22, 2022

The future towards the safer treatment of pain will come as biopharma, and investor communities appreciate the significant opportunities in supporting scientifically rigorous and clinically validated lead assets for the safer treatment of pain.

Biopharma 104

Biopharma Leads 104

Fierce Pharma

OCTOBER 22, 2023

MADRID—Attendees for the European Society for Medical Oncology Congress 2023 arrived in Madrid to torrential downpours Thursday evening, a gloomy atmosphere that did not reflect the overall excitem | ESMO attendees arrived in Madrid to torrential downpours Thursday evening, a gloomy atmosphere that did not reflect the overall excitement of an industry (..)

Medical 263

Medical 263

PharmaTimes

MARCH 24, 2023

21GRAMS takes four Golds plus Best in Show AstraZeneca tops the pharma leader board

Pharma 86

Pharma 86

Pharmacy Times

OCTOBER 31, 2022

Pharmacy Times will be covering the American Society of Consultant Pharmacists (ASCP) Annual Meeting, which will be gathering senior care pharmacists in San Antonio, Texas.

Consulting 48

Consulting 48

Fierce Pharma

DECEMBER 12, 2023

Another data face-off between the two anti-CD38 multiple myeloma drugs—Johnson & Johnson’s Darzalex and Sanofi’s Sarclisa—took place at the 65th American Society of Hematology meeting. Another data face-off between the two anti-CD38 multiple myeloma drugs—J&J's Darzalex and Sanofi's Sarclisa—took place at the ASH conference.

Patients 245

Patients 245

Pharmacy Times

NOVEMBER 1, 2022

Pharmacy Times will be covering the American Society of Nephrology (ASN) Kidney Week, which will be gathering more than 10,000 professionals working on kidney health in Orlando, Florida.

49

49

PharmExec

FEBRUARY 8, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmacy Times

NOVEMBER 30, 2022

Pharmacy Times will be covering the American Society of Health-System Pharmacists 2022 Midyear Clinical Meeting from December 4 to 8.

49

49

Fierce Pharma

JULY 17, 2023

Apellis Pharmaceuticals' Syfovre, after achieving the first FDA approval for advanced eye disease geographic atrophy, has been associated with rare but severe side effects, according to the America | The American Society of Retinal Specialists sent out a note to doctors on Saturday warning of eye inflammation cases in patients who took Syfovre, (..)

Side effects 246

Side effects Doctors FDA Pharmaceutical 246

Fierce Pharma

AUGUST 28, 2023

With seven posters and nine presentations on Farxiga over the weekend at the European Society of Cardiology (ESC) scientific sessions in Amsterdam, AstraZeneca made it clear that it has lots to say | As AstraZeneca's Farxiga has added four indications over the last five years—on top of its initial 2014 approval for Type 2 diabetes—its spillover (..)

246

246

Fierce Pharma

OCTOBER 20, 2023

On the verge of a $43 billion powerhouse merger with Pfizer, Seagen has two Presidential Symposium presentations at the European Society of Medical Oncology (ESMO) Congress in Madrid, further evide | Seagen and Genmab's Tivdak produced a 30% reduction in the risk of death compared to chemotherapy for cervical cancer patients following disease (..)

Patients 170

Patients Medical 170

MedCity News

DECEMBER 10, 2023

During the annual meeting of the American Society of Hematology, the company presented a full look at the results, which are expected to support regulatory submissions soon. Pfizer already reported its experimental drug for hemophilia A and B met a pivotal study’s goals of reducing bleeding episodes.

FDA 113

FDA Biopharma Pharma 113

Pharmacy Times

DECEMBER 8, 2022

Pharmacy Times will be covering the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, which gathers pharmacy professionals working in malignant and classical hematology in New Orleans, Louisiana.

26

26

MedCity News

JUNE 4, 2023

The study results were presented during the 2023 annual meeting of the American Society of Clinical Oncology. A Servier drug candidate acquired as part of a $1.8 billion deal kept a particular type of brain cancer from progressing in a Phase 3 clinical trial.

Patients 109

Patients Biopharma Pharma 109

PharmaVoice

JANUARY 17, 2023

Marcus Delatte discusses how and why he focuses his expertise on counseling smaller companies and mentoring the next generation of technical experts.

52

52

pharmaphorum

JANUARY 18, 2024

AI-powered patient risk assessment company C2-Ai and the Sickle Cell Society have won an NHS contest to find solutions that can tackle health inequality

Healthcare 101

Healthcare Healthcare Patients 101

MedCity News

JUNE 11, 2023

During the annual meeting of the American Society of Clinical Oncology, a cell therapy posted clinical data during that could broaden its use in multiple myeloma. In other developments, the class of drugs called ADCs continue to make progress and a novel brain cancer drug has Phase 3 data that support its use as a new treatment option.

109

109

MedCity News

NOVEMBER 28, 2023

They will still require investments from society in the interim, but that investment will be justified by the public good and eventually represent a windfall to taxpayers. Hospitals that are able to transform what they are and how they operate can survive and serve the public well.

113

113

MedCity News

JUNE 5, 2023

The data were presented during the annual meeting of the American Society of Clinical Oncology. In a confirmatory Phase 3 test of ImmunoGen’s Elahere, the ovarian cancer drug handily beat chemotherapy with results that clinicians say could make the treatment the new standard of care for certain patients.

Doctors 96

Doctors Patients Biopharma Pharma 96

MedCity News

JUNE 5, 2023

Interim Phase 2 data reported at the annual meeting of the American Society of Clinical Oncology suggest the AstraZeneca and Daiichi Sankyo drug has potential to treat many of these cancers. The HER2 protein targeted by the approved cancer drug Enhertu is found on a wide range of tumors.

Biopharma 95

Biopharma Pharma 95

MedCity News

DECEMBER 11, 2022

Data from the Phase 1/2 study supporting the biologics license application were presented in New Orleans during the annual meeting of the American Society of Hematology. Johnson & Johnson is seeking FDA approval of a multiple myeloma drug that could become the first one addressing a novel target called GPRC5D.

FDA 113

FDA Biopharma Pharma 113

MedCity News

DECEMBER 9, 2022

The deal announced Friday came as Arcellx reported additional data during the annual meeting of the American Society of Hematology that showed continued durability of the cell therapy. .

Biopharma 117

Biopharma Pharma 117

PharmExec

NOVEMBER 17, 2023

Shields discusses Ferring’s recent $5 million endowment to the American Society of Reproductive Medicine.

Pharmaceutical 105

Pharmaceutical Medicine 105

MedCity News

DECEMBER 13, 2022

The results were presented Tuesday during the annual meeting of the American Society of Hematology. Nearly all patients treated with the Novartis drug iptacopan achieved the hemoglobin goals of pivotal study compared to zero patients who received the AstraZeneca drugs that are the standard of care in a rare blood disorder.

FDA 104

FDA Patients Biopharma Pharma 104

MedCity News

JUNE 16, 2022

The nonprofit Digital Medicine Society is partnering with the likes of Google and the FDA to develop a free resource designed to help digital health startups navigate the regulatory process.

Medicine 104

Medicine FDA 104

MedCity News

OCTOBER 16, 2022

As society becomes more open to and reliant on these tools, it is the responsibility of technology companies, especially those tasked with assisting people’s mental health, to build and maintain artificial intelligence and machine learning models that adapt alongside societal needs.

145

145